Aug 10, 2026 07:30AM
Aug 4, 2026 06:00AM
Aug 4, 2026 05:15AM
Jul 14, 2026 07:32AM
Jul 14, 2026 07:30AM
Jul 9, 2026 07:30AM
Jul 9, 2026 07:30AM CervoMed Announces Completion of Enrollment in Phase 2 Study of Neflamapimod for Nonfluent Variant Primary Progressive Aphasia, a Type of Frontotemporal Dementia
Jul 6, 2026 07:30AM
Jul 6, 2026 07:30AM
Jun 18, 2026 07:00AM
Jun 18, 2026 07:00AM
Jun 16, 2026 03:22PM
Jun 16, 2026 10:18AM
Jun 10, 2026 07:30AM CervoMed raises $10.5 million, seeks partnership for dementia drug
Jun 10, 2026 07:30AM
May 18, 2026 07:30AM
Apr 22, 2026 07:30AM
Apr 7, 2026 07:30AM
Apr 7, 2026 07:30AM
Mar 19, 2026 07:31AM
Mar 19, 2026 07:30AM CervoMed Announces New Data at the AD/PD™ 2026 Scientific Conference that Reinforce Neflamapimod’s Positive Effects in Dementia with Lewy Bodies (DLB) in Patients without Alzheimer’s Disease Co-
Mar 17, 2026 07:30AM
Mar 12, 2026 07:00AM
Mar 4, 2026 07:30AM
Mar 4, 2026 07:30AM
Feb 18, 2026 06:02AM
Feb 18, 2026 06:00AM
Dec 4, 2025 05:00PM CervoMed reports positive Phase 2b trial results for dementia treatment
Dec 4, 2025 05:00PM
Dec 2, 2025 07:01AM
Dec 2, 2025 07:00AM
Nov 24, 2025 07:00AM
Nov 10, 2025 07:00AM
Nov 4, 2025 07:00AM
Nov 4, 2025 07:00AM CervoMed Announces Alignment with FDA on Registration Path for Neflamapimod in Dementia with Lewy Bodies
Oct 28, 2025 08:03AM
Oct 28, 2025 08:00AM
Oct 8, 2025 07:00AM
Oct 8, 2025 07:00AM
Oct 7, 2025 08:01AM
Oct 7, 2025 08:00AM
Sep 17, 2025 07:30AM CervoMed Highlights Neflamapimod's Potential Benefits in Session on Dementia with Lewy Bodies at the 150th Annual American Neurology Association Conference
Aug 11, 2025 08:00AM
Jul 28, 2025 07:01AM
Jul 28, 2025 07:00AM
Jun 10, 2025 08:00AM
May 12, 2025 08:00AM
Apr 2, 2025 07:00AM
Mar 17, 2025 08:00AM CervoMed Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Updates
Mar 10, 2025 04:05PM

1,177,784 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All